Pre-order Enquiry
Request Free Sample
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17294254 | Publishing Date : 29-Jan-2021 | No. of pages : 126
Detailed TOC of Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Raltegravir
1.2.3 Elvitegravir Combination Drugs
1.2.4 Dolutegravir and Its Combination Drug
1.2.5 Bictegravir Combination Drug
1.2.6 Cabotegravir
1.2.7 Other
1.3 Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2016-2027)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Regions
2.2.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Share by Regions (2016-2021)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2022-2027)
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Dynamic
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
2.3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
2.3.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2016-2021)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2016-2021)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2020
3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served
3.6 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
3.7 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Type
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2016-2021)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027)
5 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Application
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2016-2021)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
6.2.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021)
6.2.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027)
6.2.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027)
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
6.3.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021)
6.3.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027)
6.3.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
6.4.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021)
6.4.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
7.2.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021)
7.2.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027)
7.2.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
7.3.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021)
7.3.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027)
7.3.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
7.4.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021)
7.4.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027)
8.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
8.2.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027)
8.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
8.3.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027)
8.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region
8.4.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027)
9.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
9.2.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021)
9.2.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027)
9.2.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027)
9.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
9.3.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021)
9.3.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027)
9.3.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027)
9.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
9.4.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021)
9.4.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2016-2027)
10.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
10.2.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2027)
10.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
10.3.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2027)
10.4 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country
10.4.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Details
11.1.2 Adcock Ingram Limited Business Overview
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.1.5 Adcock Ingram Limited Recent Development
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Details
11.2.2 Affine Formulations Limited Business Overview
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.2.5 Affine Formulations Limited Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.3.5 Aurobindo Pharma Recent Development
11.4 Biocon Limited
11.4.1 Biocon Limited Company Details
11.4.2 Biocon Limited Business Overview
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.4.5 Biocon Limited Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Details
11.7.2 Emcure Pharmaceuticals Business Overview
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.7.5 Emcure Pharmaceuticals Recent Development
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Details
11.8.2 Flamingo Pharmaceuticals Limited Business Overview
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.8.5 Flamingo Pharmaceuticals Limited Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.9.5 Gilead Sciences Recent Development
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Details
11.10.2 Hetero Drugs Business Overview
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.10.5 Hetero Drugs Recent Development
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Details
11.11.2 IPCA Laboratories Business Overview
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.11.5 IPCA Laboratories Recent Development
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Details
11.13.2 LAURUS Labs Business Overview
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.13.5 LAURUS Labs Recent Development
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Details
11.14.2 Medisist Pharma Business Overview
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.14.5 Medisist Pharma Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.15.5 Merck Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.16.5 Mylan Recent Development
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Details
11.17.2 Ranbaxy Pharmaceuticals Business Overview
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.17.5 Ranbaxy Pharmaceuticals Recent Development
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Details
11.18.2 Shanghai Desano Pharmaceuticals Business Overview
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
11.18.5 Shanghai Desano Pharmaceuticals Recent Development
11.18 ViiV Healthcare (GSK)
.1 ViiV Healthcare (GSK) Company Details
.2 ViiV Healthcare (GSK) Business Overview
.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
.5 ViiV Healthcare (GSK) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Raltegravir
Table 3. Key Players of Elvitegravir Combination Drugs
Table 4. Key Players of Dolutegravir and Its Combination Drug
Table 5. Key Players of Bictegravir Combination Drug
Table 6. Key Players of Cabotegravir
Table 7. Key Players of Other
Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2016-2021)
Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2022-2027)
Table 14. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends
Table 15. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
Table 16. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2016-2021)
Table 20. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020)
Table 21. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
Table 25. Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2016-2021)
Table 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2016-2021)
Table 33. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Adcock Ingram Limited Company Details
Table 66. Adcock Ingram Limited Business Overview
Table 67. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 68. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 69. Adcock Ingram Limited Recent Development
Table 70. Affine Formulations Limited Company Details
Table 71. Affine Formulations Limited Business Overview
Table 72. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 73. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 74. Affine Formulations Limited Recent Development
Table 75. Aurobindo Pharma Company Details
Table 76. Aurobindo Pharma Business Overview
Table 77. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 78. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 79. Aurobindo Pharma Recent Development
Table 80. Biocon Limited Company Details
Table 81. Biocon Limited Business Overview
Table 82. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 83. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 84. Biocon Limited Recent Development
Table 85. Bristol-Myers Squibb Company Details
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 88. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. Cipla Company Details
Table 91. Cipla Business Overview
Table 92. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 93. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 94. Cipla Recent Development
Table 95. Emcure Pharmaceuticals Company Details
Table 96. Emcure Pharmaceuticals Business Overview
Table 97. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 98. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 99. Emcure Pharmaceuticals Recent Development
Table 100. Flamingo Pharmaceuticals Limited Company Details
Table 101. Flamingo Pharmaceuticals Limited Business Overview
Table 102. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 103. Flamingo Pharmaceuticals Limited Recent Development
Table 104. Gilead Sciences Company Details
Table 105. Gilead Sciences Business Overview
Table 106. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 107. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 108. Gilead Sciences Recent Development
Table 109. Hetero Drugs Company Details
Table 110. Hetero Drugs Business Overview
Table 111. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 112. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 113. Hetero Drugs Recent Development
Table 114. IPCA Laboratories Company Details
Table 115. IPCA Laboratories Business Overview
Table 116. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 117. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 118. IPCA Laboratories Recent Development
Table 119. Janssen Pharmaceutica (Johnson & Johnson) Company Details
Table 120. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
Table 121. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 122. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 123. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table 124. LAURUS Labs Company Details
Table 125. LAURUS Labs Business Overview
Table 126. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 127. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 128. LAURUS Labs Recent Development
Table 129. Medisist Pharma Company Details
Table 130. Medisist Pharma Business Overview
Table 131. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 132. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 133. Medisist Pharma Recent Development
Table 134. Merck Company Details
Table 135. Merck Business Overview
Table 136. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 137. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 138. Merck Recent Development
Table 139. Mylan Company Details
Table 140. Mylan Business Overview
Table 141. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 142. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 143. Mylan Recent Development
Table 144. Ranbaxy Pharmaceuticals Company Details
Table 145. Ranbaxy Pharmaceuticals Business Overview
Table 146. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 147. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 148. Ranbaxy Pharmaceuticals Recent Development
Table 149. Shanghai Desano Pharmaceuticals Company Details
Table 150. Shanghai Desano Pharmaceuticals Business Overview
Table 151. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 152. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 153. Shanghai Desano Pharmaceuticals Recent Development
Table 154. ViiV Healthcare (GSK) Company Details
Table 155. ViiV Healthcare (GSK) Business Overview
Table 156. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 157. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021) & (US$ Million)
Table 158. ViiV Healthcare (GSK) Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2020 VS 2027
Figure 2. Raltegravir Features
Figure 3. Elvitegravir Combination Drugs Features
Figure 4. Dolutegravir and Its Combination Drug Features
Figure 5. Bictegravir Combination Drug Features
Figure 6. Cabotegravir Features
Figure 7. Other Features
Figure 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Drug Center Case Studies
Figure 12. Other Case Studies
Figure 13. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions: 2020 VS 2027
Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Regions (2022-2027)
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2020
Figure 19. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2020
Figure 20. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2020
Figure 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2016-2021)
Figure 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2022-2027)
Figure 23. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027)
Figure 25. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027)
Figure 26. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027)
Figure 27. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027)
Figure 31. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027)
Figure 32. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027)
Figure 33. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027)
Figure 41. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027)
Figure 42. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2016-2027)
Figure 43. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027)
Figure 51. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027)
Figure 52. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027)
Figure 53. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type (2016-2027)
Figure 57. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application (2016-2027)
Figure 58. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2016-2027)
Figure 59. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 63. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 64. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 65. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 67. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 68. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 69. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 71. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 72. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 73. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 74. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 75. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 76. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 77. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 78. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 79. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 80. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
Keyplayers in Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, Status and Forecast 2021-2027
Adcock Ingram LimitedAffine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Request Sample
Request Discount
